Researchers conducted the study at a 700-bed academic medical center, aggregating data from all adult patients admitted to the hospital’s intensive care units during a pre-intervention period (from January to December 2012) and a post-intervention period (from January to December 2013).
Highlighted below are three things to know about the study.
1. The intervention implemented was a new protocol limiting the number of urine cultures ordered to cases in which pyuria — which is frequently associated with bacterial infection — was detected.
2. Results of the study indicated a decrease in the number of patients starting a new antimicrobial therapy based on urine culture results after the intervention was implemented, from 41 percent to 23 percent.
3. The researchers did not observe a statically significant difference in the average total days of antimicrobial therapy among patients after the intervention.
More articles on antimicrobials:
Serving antibiotic-free meet proves difficult for some hospitals
NIH commits $5M to fund research projects on antibiotic alternatives
Naturally occurring food preservatives kill cancer, antibiotic-resistant bugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
